Ironwood Pharmaceuticals Inc (IRWD)
8.12
-0.18
(-2.17%)
USD |
NASDAQ |
May 03, 16:00
8.115
0.00 (0.00%)
Pre-Market: 20:00
Ironwood Pharmaceuticals Cash from Operations (Quarterly): 35.83M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 35.83M |
| September 30, 2023 | 32.46M |
| June 30, 2023 | 34.96M |
| March 31, 2023 | 80.17M |
| December 31, 2022 | 79.18M |
| September 30, 2022 | 69.09M |
| June 30, 2022 | 61.36M |
| March 31, 2022 | 64.12M |
| December 31, 2021 | 64.57M |
| September 30, 2021 | 75.06M |
| June 30, 2021 | 48.57M |
| March 31, 2021 | 73.69M |
| December 31, 2020 | 51.51M |
| September 30, 2020 | 53.63M |
| June 30, 2020 | 20.09M |
| March 31, 2020 | 43.60M |
| December 31, 2019 | 27.58M |
| September 30, 2019 | 34.77M |
| June 30, 2019 | -9.237M |
| March 31, 2019 | -42.38M |
| December 31, 2018 | 9.273M |
| September 30, 2018 | -26.58M |
| June 30, 2018 | -22.69M |
| March 31, 2018 | -30.89M |
| December 31, 2017 | -9.214M |
| Date | Value |
|---|---|
| September 30, 2017 | -31.24M |
| June 30, 2017 | -32.45M |
| March 31, 2017 | -27.85M |
| December 31, 2016 | -19.19M |
| September 30, 2016 | -0.645M |
| June 30, 2016 | -6.263M |
| March 31, 2016 | 0.161M |
| December 31, 2015 | -19.36M |
| September 30, 2015 | -26.23M |
| June 30, 2015 | -25.55M |
| March 31, 2015 | -35.78M |
| December 31, 2014 | -22.78M |
| September 30, 2014 | -38.68M |
| June 30, 2014 | -36.21M |
| March 31, 2014 | -57.89M |
| December 31, 2013 | -42.08M |
| September 30, 2013 | -57.95M |
| June 30, 2013 | -80.14M |
| March 31, 2013 | -93.18M |
| December 31, 2012 | -22.46M |
| September 30, 2012 | 39.00M |
| June 30, 2012 | -43.11M |
| March 31, 2012 | -43.06M |
| December 31, 2011 | -7.701M |
| September 30, 2011 | -25.42M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-9.237M
Minimum
Jun 2019
80.17M
Maximum
Mar 2023
49.53M
Average
51.51M
Median
Dec 2020
Cash from Operations (Quarterly) Benchmarks
| Societal CDMO Inc (DELISTED) | 1.527M |
| Mirum Pharmaceuticals Inc | -16.62M |
| Tharimmune Inc | -1.415M |
| Kineta Inc | -4.075M |
| Moderna Inc | -989.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -4.188M |
| Cash from Financing (Quarterly) | -50.90M |
| Free Cash Flow | 183.15M |
| Free Cash Flow Per Share (Quarterly) | 0.2283 |
| Free Cash Flow to Equity (Quarterly) | 60.22M |
| Free Cash Flow to Firm (Quarterly) | 35.21M |
| Free Cash Flow Yield | 13.17% |